Neurogene: And Exhibits 99.1 And 99.2 Attached Hereto Are Being Furnishedand Shall Not Be Deemed “filed” For The Purposes Of Section18 Of The Securities Exchange Act Of 1934, As Amended (the "exchange Act"), Or Otherwise Subject To The Liabilities Of That Section, Nor Shall Such Information Or Exhibits 99.1 And 99.2 Be Deemed Incorporated By Reference Into Any Filing Under The Exchange Act Or The Securities Act Of 1933, As Amended, Except As Expressly Set Forth By Specific Reference To Such Filing, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Neurogene, Inc
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***